65 -- DIAGNOSTIC REAGENTS

Notice Date

March 1, 2001

Contracting Office

Acquisitions Management Operations Branch, NIAID, 6700-B Rockledge Drive, Room 1130, Bethesda, MD 20892-7605

ZIP Code

20892-7605

Solicitation Number

NOI1001

Response Due

March 14, 2001

Point of Contact

Guy Baratte, Purchasing Agent (301) 594-5075/Carolyn Sentz, Contracting Officer (301) 402-2282

Description

17. This is a combined synopsis/solicitation notice of intent for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are not being requested and a written solicitation will not be issued. The solicitation number for this acquisition is NOI1001 and the solicitation is being issued as a notice of intent. This solicitation document and its incorporated provisions are those in effect through Federal Acquisition Circular FAC 97-23. The National Institute of Allergy and Infectious Diseases intends to negotiate on a sole-source basis using simplified acquisition procedures with Abbott Diagnostics of Chicago, IL for the following diagnostic reagents and enzyme immunoassay kits in the quantities indicated: Auszyme Monoclonal Kit, Cat. No. 1980-24, fifteen (15) each; AntiDelta Reagent, Cat. No. 3018-22, six (6) each; Ausab EIA Kit, Cat. No. 9006-24, fifteen (15) each; Corzyme EIA Kit, Cat. No. 9977-24, fifteen (15) each; Corzyme-M EIA Kit, Cat. No. 1236-24, two (2) each; Havab-EIA, Cat. No. 7895-24, twenty-five (25) each; Havab-M-EIA Kit, No Cat. No., four (4) each; HBE EIA Kit, Cat. No. 1235-24, eight (8) each; HCV-EIA, Cat. No. 4A14-24, twelve (12) each; HIV-EIA 1 & 2, Cat. No. 3A77-29, two (2) each and EIA Accessories Kit(s), Cat. No. 5785-24, ten (10) each. This is not a Small-Business Set Aside. The North American Industry Classification System (NAICS) Code for this acquisition is 325413 and the small-business size standard is 500. These items will be delivered to a NIAID facility in Rockville, MD at intervals and in quantities to be determined by the end-user. This is a fixed-price contract and the FOB terms are "Destination." The anticipated period of performance will be 03/19/01 9/30/01. These items will be used to perform immunological tests to detect, analyze and quantify markers of hepatitis and human immunodeficiency virus on a wide variety of specimens. The tests performed will include Hepatitis A, B, C, D and Human Immunodeficiency Virus. These same kits and reagents have been used for over twenty years for consistency of results. It is essential that the same reagents continue to be used in order to maintain data integrity. Changing variables would prevent the correct interpretation of the experiment and thus cause harm to the existing experiment and mission of the Institute. FAR provisions and clauses that apply to this acquisition: FAR 52.212-1, Instructions to Offerors Commercial Items; FAR 52.212-3, Offeror Representations and Certifications Commercial Items; FAR 52.212-4, Contractor Terms and Conditions Commercial Items; FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items. FAR 52.225-3, Buy American Act also applies. Offerors must include with their offer a completed copy of the provisions at FAR 52.212-3, Offerors Representations and Certifications Commercial Items. Offers must be submitted no later than 4:30 P.M. Eastern Standard Time March 15, 2001. For delivery of responses through the Postal Service, the address is NIH/NIAID/AMOB, 6700B Rockledge Drive/MSC7605, Room 1130, Bethesda, Maryland 20892-7605. Electronic submissions will not be accepted. Requests for information concerning this requirement are to be addressed to Guy Baratte at (301) 594-5075. Collect calls will not be accepted.

Record

Loren Data Corp. 20010302/65SOL002.HTM (W-059 SN50E8U8)